MBLinhibitors.com, a Website Resource Offering Information and Expertise for the Continued Development of Metallo-β-Lactamase Inhibitors is a dataset published in Biomolecules (2020). On theSindex it has a DataRank of 0.667, placing it in the top 29.9% of the data-sharing corpus. It has been cited 10 times, with 7 citing works in its 1-hop citation network.
Ranks in the top 30% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0.307
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
National Institutes of Health
Grant: GM111926
National Institutes of Health
Grant: GM134454
National Science Foundation
Grant: CHE-1851795
NIGMS NIH HHS
Grant: R01 GM111926
NIGMS NIH HHS
Grant: R15 GM134454
National Institutes of Health
Grant: 5R01GM111926-04
Developing Metallo-Beta-Lactamase Inhibitors
National Institutes of Health
Grant: 1R15GM134454-01
Determining the mechanism of inhibition of metallo-b-lactamase inhibitors
FWCI
0.56
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals